PROGRAM OVERVIEW:
COURSE HIGHLIGHTS

There are several unique features that set this course apart from the others:

• Expert Faculty- Our faculty, unmatched in experience and expertise, will present the latest scientific findings in Hematology and Oncology, and best practices in the advances in cancer prevention, diagnosis, treatment, and survivorship.
• Daily Board Review Sessions- Allows attendees to gauge their knowledge base and become familiar with board-type questions
• Access to high quality video presentations featuring the nation's leading clinician-educators (streaming media). You will have access to this course until Saturday, December 31, 2022.
• All content can be conveniently accessed from any computer, mobile device, or smartphone
• Access to the Course Electronic Syllabus and Slide Handouts
• CME Credits and MOC points

CME & MOC

Attending 2021 HEMONC is an excellent way to fulfill your continuing medical education requirements. 2021 HEMONC attendees can also earn MOC points by reviewing the sessions.

This course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as for Oncology Nurse Practitioners, Nurses, Physician Assistants, Pharmacists, Advanced Practice Providers, Allied Professionals and other Healthcare Providers desiring a comprehensive review of hematology and medical oncology standards of care.

At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

Hematology

• Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
• Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
• Understand blood and marrow morphology and hematopathology
• Understand red cell disorders

Hematologic Malignancies

• Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
• Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
• Identify strategies for taking the board examinations

Oncology

• Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
• Understand the principles of management of gynecologic and other genito-urinary malignancies
• Recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
• Recognize principles of new developments in biologic therapy of cancer
• Contend with complexity of HIV related malignancies

Oncology Update

• Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with cancer
• Implement new patient management and care strategies or revise existing ones
• Examine advances in clinical and translational cancer research

PHYSICIAN CME CREDIT

The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 79.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACIST CME CREDIT

The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

GROUP REGISTRATIONS:

• For group registrations over (5) five participants, please email your request to Bielka Mora at bielka.mora@finaww.com.

COURSE MATERIALS | COURSE ACCESS:

• This course includes the following materials to support your learning experience: Course electronic Syllabus, PDF Slide Handouts, Video Presentation Lectures and Board Review Type Questions
• You will have access to this online course until Saturday, December 31, 2022.

PURCHASE DISCLAIMER:

• Please note that the Ethos CE System is designed to track individual learning. The learning system does not permit shared logins, any attempt of this activity will be monitored and your subscription will be at risk to be suspended at GW's discretion.